Medical therapy of urinary tract infection;Medikamentöse therapie von harnwegsinfekten

Internist

Volumn 49, Issue 6, 2008, Pages 747-755

  Stein, G ^a   Funfstuck R ^b  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b Sophien und Hufelandklinikum Weimar

Author keywords

Antibiotic therapy; Resistance; Urinary tract infection; Uropathogens

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALEXIN; CEFOTAXIME; CEFPODOXIME PROXETIL; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; FLEROXACIN; FOSFOMYCIN TROMETAMOL; GENTAMICIN; LEVOFLOXACIN; METHENAMINE; METHIONINE; NITROFURANTOIN; NITROXOLINE; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TRIMETHOPRIM; VACCINE;

ACUPUNCTURE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIURIA; COMMUNICABLE DISEASE; ESCHERICHIA COLI; HUMAN; INFECTION PREVENTION; INFECTION RESISTANCE; MONOTHERAPY; MORBIDITY; SHORT COURSE THERAPY; URINARY TRACT INFECTION;

ADULT; AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; BACTERIURIA; COMBINED MODALITY THERAPY; CROSS INFECTION; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREGNANCY; RECURRENCE; RISK FACTORS; SEX FACTORS; URINARY TRACT INFECTIONS;

EID: 44949140659     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-008-2036-9     Document Type: Article

References (32)

1. Aune A, Alraek T, LiHua H et al. (1998) Acupuncture in the prophylaxis of recurrent lower urinary tract infection in adult women. Scand J Prim Health Care 16: 37-39
2. Bailey BL (1995) Urinalysis predictive of urine culture results. J Fam Pract 40: 45-50
3. Bouza E, San Juan R, Munoz P et al. (2001) A European perspective on nosocomial urinary tract infections II Report on incidence, clinicial characteristics and outcome (ESGNI 004 study). Clin Microbiol Infect 7: 532-542
4. Bührlen U (2007) In-vitro Wirksamkeit von Nitroxolin forte. http://www.rosen-pharma.de
5. Carter JL, Tomson CR, Stevens PE, Lamb EJ (2006) Does urinary tract infection cause proteinuria or microalbuminuria? A systematic review. Nephrol Dial Transplant 21: 3031-3037
6. Ferry SA, Holm SE, Stenlund H et al. (2004) The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study. Scand J Infect Dis 36: 296-301
7. Franz M (1992) Die Behandlung von Harnwegsinfektionen mit Nitroxolin. Z Allg Med 68: 526-530
8. Fünfstück R, Stein G (2002) Harnwegsinfektionen bei Diabetes mellitus. Spectr Diabetes 4: 7-13
9. Fünfstück R, Straube E, Schildbach O, Tietz U (1997) Reinfektionsprophylaxe durch L-Methionin bei Patienten mit einer Harnwegsinfektion. Med Klin 92: 574-581
10. Heinrich S (2007) Harnwegs- und Cytomegalieinfektion nach Nierentransplantation. Dissertation FSU, Jena
11. Hu KK, Boyko EJ, Scholes D et al. (2004) Risk factor for urinary tract infection in postmenopausal women. Arch Intern Med 164: 989-993
12. Hyodo T, Yoshida K, Sakai T, Baba T (2005) Asymptomatic hyperleukocyturia in hemodialysis patients analyzed by the automated urinary flow cytometer. Ther Apher Dial 9: 402-406
13. Jepson RG, Mihaljevic L, Craig J (2006) Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2: CD001321
14. Kahlmeter G, Menday P (2003) Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. J Antimicrob Chemother 52: 128-131
15. Lee BB, Simpson JM, Craig JC, Bhuta T (2007) Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev. 4: CD003265
16. Lobel B (2003) Short term therapy for uncomplicated urinary tract infection today. Clinical outcome upholds the theories. Int J Antimicrob Agents 22: S85-S87
17. Mühldorfer I, Hacker J (1999) Pathogenitätscharakteristika potentieller Infektionserreger im Urogenitaltrakt. Nieren Hochdruckkr 3: 78-84
18. Naber KG, Brühl P, Fünfstück R et al. (2001) Empfehlungen zur antimikrobiellen Therapie von Harnwegsinfektionen. J Urol Urogynäkol 3: 16-19
19. Nicolle LE, Bradley S, Colgan R et al. (2005) Infectious diseases society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 40: 643-654
20. Oelschlaeger T, Fünfstück R (2006) Rezidivierende Harnweginfektionen der Frau. Erregervirulenz und Wirtsreaktion. Urologe 45: 412-420
21. Ott U, Werner T, Wolf G (2007) Harnwegsinfektionen nach Nierentransplantation. Nieren Hochdruckkr 36: 489-495
22. Pappas PG, Rex JH, Sobel JD (2004) Guidelines for treatment of candidiasis. Clin Infect Dis 138: 161-189
23. Pohl A ( 2007) Modes of administration of antibiotics for symptomatic severe urinary tract infection. Cochrane Database Syst Rev 4: CD003237
24. Raz R (2001) Hormone replacement therapy or prophylaxis in postmenopausal women with recurrent urinary tract infection. J Infect Dis (Suppl 1) 183: S74-S76
25. Richards D, Toop L, Chambers S, Flechter L (2005) Response to antibiotics of woman with symptoms of urinary tract infection but negative dipstick urine test results: double-blind randomised controlled trial. BMJ 331: 143-147
26. Säemann MD, Weichhart T, Zeyda M et al. (2005) Tamm-Horsefall glycoprotein links innate immune cell activation with adaptive immunity via a toll-like receptor-4-dependent mechanism. J Clin Invest 115: 468-475
27. Schito G (2007) Epidemiology and resistance in uncomplicated UTI - a recent European study (ARESC); 25th International Congress on Chemotherapy and the 17th European Congress of Clinical Microbiology and Infectious Diseases, München
28. Stapleton A, Latham RH, Johnson C et al. (1990) Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, double-blind, placebo-controlled trial. JAMA 364: 703-706
29. Stein G, Eichhorn T, Fünfstück R (2007) Harnwegsinfektion bei Patienten mit eingeschränkter Nierenfunktion. Nieren Hochdruckkr 36: 288-291
30. Ulleryd P(2003) Febrile urinary tract infection in men. Int J Antimicrob Agents 22: S89-S93
31. Vazquez JC, Villar J (2007) Treatments for symptomatic urinary tract infections during pregnancy. Cochrane Syst Rev 4: CD002256
32. Wagenlehner FME, Niemetz A, Weidner W, Naber KG (2008) Spectrum and antibiotic resistance of uropatogens from hospitalised patients with urinary tract infections: 1994-2005. Int J Antimicrob Agents (in press)